Despite global decrease, Chagas disease is rising in non-endemic regions
On Nov. 6, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
WHO publishes new global research agenda to strengthen paediatric clinical trials
On Nov. 6, 2025, the World Health Organization (WHO) released a technical report, The future of paediatric clinical trials…
Oxford scientists capture genome’s structure in unprecedented detail
On Nov. 6, 2025, scientists from Oxford’s Radcliffe Department of Medicine have achieved the most detailed view yet…
CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion
On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…
Phage G genome: AI analysis maps out world’s largest cultivated bacteria-killing virus
On Oct. 29, 2025, University of North Carolina at Charlotte (UNC) researchers leading a multidisciplinary team across four…
Rice launches Brain Institute to accelerate discoveries in brain science and health
On Oct. 29, 2025, Rice University announced the creation of the Rice Brain Institute (RBI), an ambitious, interdisciplinary…
Lilly partners with Nvidia on AI supercomputer to speed up drug development
On Oct. 28, 2025, Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer…
Novartis to acquire Avidity Biosciences, an innovator in RNA therapeutics for $11 Billion
On Oct. 26, 2025, Novartis announced that it has entered into an agreement to acquire Avidity Biosciences, a…
Lilly to Acquire Adverum Biotechnologies for $12.47 per Share
On Oct. 24, 2025, Eli Lilly and Adverum Biotechnologies announced a definitive agreement for Lilly to acquire Adverum,…
Alkermes Announces Agreement to Acquire Avadel Pharmaceuticals for $2.1 billion
On Oct. 22, 2025, Alkermes and Avadel Pharmaceuticals announced the companies have entered into a definitive agreement under…
South Carolina Department of Public Health Confirms Measles Outbreak
On Oct. 22, 2025, the South Carolina Department of Public Health (SCDPH) announced it is actively responding to…
Pigs developed to be resistant to deadly virus
On Oct. 22, 2025, a Roslin Institute led team announced they have developed pigs that are resistant to…
Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia
On Oct. 20, 2025, Merck announced the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility…
Glaukos Announces FDA Approval of Epioxa™
On Oct. 20, 2025, Glaukos announced today the U.S. Food and Drug Administration (FDA) approved its Epioxa™ HD…
The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients
On Oct. 20, 2025, The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, announced it…
ACG to invest $200 million in U.S. hard-shell capsule manufacturing
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
Setback for Roche in Natco Pharma case as India Supreme Court allows generic drug sales
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
Boston Scientific Announces Agreement to Acquire Nalu Medical for $533 million
On Oct. 17, 2025, Boston Scientific announced it has entered into a definitive agreement to acquire Nalu Medical,…
FDA approves Novo Nordisk’s oral semaglutide for cardiovascular risk reduction in adults with type 2 diabetes
On Oct. 17, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1…
Diagnostics | Disease | FDA | Medicine | Pharmaceutical | Therapeutics
FDA unveils drugs to receive expedited review in support of ‘national priorities’
On Oct. 16, 2025, the Food and Drug Administration (FDA) announced the first round of experimental drugs that…
Broad Clinical Labs sets new GUINNESS WORLD RECORDS™ title for fastest DNA sequencing technique
On Oct. 15, 2025, Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, announced…
Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push
On Oct. 15, 2025, Danish drugmaker Novo Nordisk and Omeros announced they have signed a licensing deal worth…
Researchers Announce a phone book-sized surgical kit designed for the world’s most extreme environments
On Oct. 14, 2025, researchers Texas A&M University School of Engineering Medicine (EnMed) announced development of a portable…
WHO warns of widespread resistance to common antibiotics worldwide
On Oct. 13, 2025, the World Health Organization (WHO) reported that one in six laboratory-confirmed bacterial infections causing…
Bristol Myers Squibb Acquires Cell Therapy Portfolio with Acquisition of Orbital Therapeutics for $1.5 billion in cash
On Oct. 10, 2025, Bristol Myers Squibb (BMS) and Orbital Therapeutics announced a definitive agreement under which BMS…
U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast) tablets as first new treatment option for adults with IPF in over a decade
On Oct. 9, 2025, Boehringer Ingelheim’s JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug…
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
On Oct. 9, 2025, Celltrion announced announced that the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), biosimilar…
Biotechnology | Clinical Research | Infectious Disease | Medical Device | Therapeutics | Vaccine | WHO
WHO launches the Global Clinical Trials Forum
On Oct. 7, 2025, the World Health Organization (WHO) launched the Global Clinical Trials Forum (GCTF), a global,…